TRIB

Trinity Biotech
TRIB

Overview Fund Activity

19 hedge funds and large institutions have $5.95M invested in Trinity Biotech in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
19
Holders Change
-7
Holders Change %
-26.92%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
6
Increased
1
Reduced
7
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$3.67M
2
MAWA
2
Moss Adams Wealth Advisors
Washington
$52.4K
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$27.8K
4
UBS Group
4
UBS Group
Switzerland
$10.6K
5
GRP
5
Global Retirement Partners
California
$1.63K

Top Sellers

1
SCM
1
Stonehill Capital Management
New York
$507K
2
Acadian Asset Management
2
Acadian Asset Management
Massachusetts
$237K
3
HAIM
3
Hunter Associates Investment Management
Pennsylvania
$644K
4
Citadel Advisors
4
Citadel Advisors
Florida
$0
5
AC
5
Aristides Capital
Kentucky
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
RWMG
26
Redwood Wealth Management Group
New Jersey
– -$6.07K -2,830 Closed
DAS
27
Dynamic Advisor Solutions
Arizona
– -$5.3K -2,000 Closed
WN
28
Williams & Novak
California
– -$4.29K -2,000 Closed
US Bancorp
29
US Bancorp
Minnesota
– -$417 -194 Closed
Citigroup
30
Citigroup
New York
– -$2 -1 Closed
1
2